secwatch / observer
8-K filed October 31, 2024, 7:59 PM ET ticker XBIO CIK 0001534525
leadership confidence high sentiment neutral materiality 0.55

Two Xenetic directors not standing for re-election at 2024 Annual Meeting

Xenetic Biosciences, Inc.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Adam Logal

member of the board of directors
XBIO · Xenetic Biosciences, Inc.
Filed
October 31, 2024, 7:59 PM ET
On October 29, 2024, James E. Callaway and Adam Logal, each a member of the board of directors (the “Board”) of Xenetic Biosciences, Inc. (the “Company”), informed the Company of their intention to not stand for re-election at the Company’s 2024 Annual Meeting of Stockholders.
Departed

James E. Callaway

member of the board of directors
XBIO · Xenetic Biosciences, Inc.
Filed
October 31, 2024, 7:59 PM ET
On October 29, 2024, James E. Callaway and Adam Logal, each a member of the board of directors (the “Board”) of Xenetic Biosciences, Inc. (the “Company”), informed the Company of their intention to not stand for re-election at the Company’s 2024 Annual Meeting of Stockholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Adam Logal departed as member of the board of directors at Xenetic Biosciences, Inc..

Action
not stand for re-election
Role
member of the board of directors
Exact text from the filing
On October 29, 2024, James E. Callaway and Adam Logal, each a member of the board of directors (the “Board”) of Xenetic Biosciences, Inc. (the “Company”), informed the Company of their intention to not stand for re-election at the Company’s 2024 Annual Meeting of Stockholders.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

James E. Callaway departed as member of the board of directors at Xenetic Biosciences, Inc..

Action
not stand for re-election
Role
member of the board of directors
Exact text from the filing
On October 29, 2024, James E. Callaway and Adam Logal, each a member of the board of directors (the “Board”) of Xenetic Biosciences, Inc. (the “Company”), informed the Company of their intention to not stand for re-election at the Company’s 2024 Annual Meeting of Stockholders.
View on SEC.gov

Xenetic Biosciences, Inc. filing history →

Source: SEC EDGAR
accession 0001683168-24-007527
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.